Title:
COMBINATION OF IAP INHIBITOR AND IMMUNE CHECKPOINT INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2020/177765
Kind Code:
A1
Abstract:
The present invention relates to a combination of a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof which are used as an IAP inhibitor, and an immune checkpoint inhibitor; and use of the combination in the preparation of a cancer treatment drug. ![]()
Inventors:
LIU YINGCHUN (CN)
XU ZHAOBING (CN)
HAN SHUHUA (CN)
HU LIHONG (CN)
DING ZHAOZHONG (CN)
XIA YUANFENG (CN)
TONG HAIJUN (CN)
HE LIHUA (CN)
TIAN XIN (CN)
XU ZHAOBING (CN)
HAN SHUHUA (CN)
HU LIHONG (CN)
DING ZHAOZHONG (CN)
XIA YUANFENG (CN)
TONG HAIJUN (CN)
HE LIHUA (CN)
TIAN XIN (CN)
Application Number:
PCT/CN2020/078234
Publication Date:
September 10, 2020
Filing Date:
March 06, 2020
Export Citation:
Assignee:
CHIA TAI TIANQING PHARMACEUTICAL GROUP CO LTD (CN)
International Classes:
A61K31/4045; A61P35/00; C07D403/06
Foreign References:
| CN101951766A | 2011-01-19 | |||
| CN101035802A | 2007-09-12 | |||
| CN101605786A | 2009-12-16 | |||
| CN101595121A | 2009-12-02 |
Other References:
LYU, SHUIPING ET AL.: "Research Progress of Molecular Targeted Drugs on Antitumor Immunity", JOURNAL OF MEDICAL RESEARCH, vol. 47, no. 9, 30 September 2018 (2018-09-30), CN, pages 9 - 12, XP009530518, ISSN: 1673-548X
See also references of EP 3936126A4
See also references of EP 3936126A4
Attorney, Agent or Firm:
LINDA LIU & PARTNERS (CN)
Download PDF:
Previous Patent: DATA TRANSMISSION GUARANTEE METHOD AND COMMUNICATION DEVICE
Next Patent: MULTIPATH SEPARATION METHOD AND DEVICE, AND STORAGE MEDIUM
Next Patent: MULTIPATH SEPARATION METHOD AND DEVICE, AND STORAGE MEDIUM